Increasing Occurrences of Neurological Diseases Fuels the Global Neurostimulation Devices Market


Posted September 29, 2017 by Dineshpatel

Global Neurostimulation devices Market is estimated to reach $10.2 Billion by 2024; growing at a CAGR of 12.7% from 2016 to 2024.

 
Global Neurostimulation Devices Market Report, published by Variant Market Research, forecast that the global market was valued at $4 Billion in 2016, and is expected to reach $10.2 Billion by 2024, growing at a CAGR of 12.7% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 13.8% and 12.9%, respectively, during the forecast period 2016-2024.

Get Full Access to This Report @ https://www.variantmarketresearch.com/report-categories/medical-devices/neurostimulation-devices-market

Increasing occurrences of neurological diseases, and higher rate of associated chronic pain & discomfort are the primary aspects by which the global neurostimulation devices market is been driven. On the other hand, upsurge in demand for add-on therapies, increasing geriatric population, rising demand for safer, less invasive, and more cost-effective treatments will also support the market growth. However, high cost of treatments along with risk associated with neurostimulation therapy may restrict the market from growing. Even though, increase in clinical trials, advancement in technology, and limited competition are expected to present potential growth opportunities over the forecast period.

Get Table of Content (TOC) @ https://www.variantmarketresearch.com/report-categories/medical-devices/neurostimulation-devices-market/toc

Device type, application, and geography are the prime segments considered in the global neurostimulation devices market. Where, device type is diverged into implantable devices (deep brain stimulation, cochlear implants, spinal cord stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electric stimulation, and others) and external devices (transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and others). Classification by application includes, Parkinson’s disease, epilepsy, pain management, hearing loss, urinary and fecal incontinence, gastroparesis, depression, and others. Among the device types, implantable devices dominated the segment with major market share in 2016. By application, pain management accounted for the largest share with respect to market and is expected to lead with fastest CAGR during the forecast period i.e. 2016-2024.

Based on geographical analysis, North America, Europe, Asia-Pacific, and Rest of the World (RoW) are considered as the major segments in the global neurostimulation devices market. Where, North America held the largest share of the total market with 45% in 2016, due to high healthcare expenditure and commercialization of advanced technologies. While, Europe accounted for the second largest market share of 28% in 2016. In terms of growth, Asia-Pacific is anticipated to grow with the fastest CAGR, owing to increasing consumer knowledge & awareness, and growing healthcare facilities.

Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/medical-devices/neurostimulation-devices-market/sample-request

The major players in the market include Cyberonics, Inc., DePuy Synthes Companies, BioControl Medical, Synapse Biomedical, Inc., Nevro Corporation, St. Jude Medical, Inc., Boston Scientific Corporation, Neuropace, Inc., NeuroSigma, Inc., NDI Medical, LLC, and among others.

Scope of the Global Neurostimulation Devices Market

Device Type Segments
• Implantable Devices
o Cochlear Implants
o Deep Brain Stimulation
o Spinal Cord Stimulation
o Vagus Nerve Stimulation
o Sacral Nerve Stimulation
o Gastric Electric Stimulation
o Others

• External Devices
o Transcranial Magnetic Stimulation (TMS)
o Transcutaneous Electrical Nerve Stimulation (TENS)
o Others

Application Segments
• Parkinson’s Disease
• Pain Management
• Epilepsy
• Hearing Loss
• Gastroparesis
• Urinary and Fecal Incontinence
• Depression
• Others

Geography Segments
• North America
o U.S.
o Canada
o Mexico

• Europe
o Germany
o UK
o France
o Others

• Asia Pacific
o China
o Japan
o India
o Others

• RoW
o South America
o Middle East
o Africa

About Variant Market Research

Variant Market Research offers syndicated and customized reports to fulfill clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.

For further information, visit https://www.variantmarketresearch.com

Contact Us:

Variant Market Research
Web: https://www.variantmarketresearch.com
Tel: +1-415-680-2785
Tel: +91 20 65337795
Fax: +1-415-680-2786
Email: [email protected]
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Dinesh Patel
Website variant market research
Phone Tel: +1-415-680-2785
Business Address 649 Mission St, 5th Floor, San Francisco, CA 94105,United States.
Country United States
Categories Medical
Tags neurostimulation devices market , neurostimulation devices market trend , neurostimulation devices market forecast , neurostimulation devices market outlook , neurostimulation devices market size
Last Updated September 29, 2017